Atrium Therapeutics, Inc. RNA
8.34 USD +0.02 (+0.24%)
At closeNov 9, 2026, 5:04 AM EST
8.36 +0.02 +0.24%
Pre-market · Nov 9, 5:04 AM ET
8.23 Day range 8.55
7.49 52-week range 16.77
- YTD
- -43.46%
- 1 year
- -43.46%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 18.62M | 10.90M | 9.76M | 9.22M | 9.33M | |
| 18.62M | 10.90M | 9.76M | 9.22M | 9.33M | |
| -49.63M | -13.22M | -6.39M | -178.91M | -118.05M | |
| -49.50M | -25.12M | -6.38M | -174.00M | -118.01M |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 8.35M | 7.19M | 10.29M | 638.80M | 427.58M | |
| 71.07M | 68.29M | 80.91M | 60.73M | 46.15M | |
| 3.67M | 6.80M | 9.85M | 10.69M | 11.73M | |
| -62.71M | -61.11M | -70.62M | 578.08M | 381.43M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -41.13M | -22.55M | 56.39M | -136.27M | -94.81M | |
| -1.45M | -266.00K | -320.00K | -189.96M | -82.52M | |
| 42.57M | 22.82M | -56.07M | 346.17M | 176.32M | |
| -1.45M | -266.00K | -320.00K | -2.82M | -3.74M |